Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7815049 | 0.93 | RORC (0.55) | RORCBDKRB2 | |
| SCHEMBL7818231 | 0.91 | RORC (0.57) | RORCBDKRB2 | |
| SCHEMBL7945796 | 0.90 | BDKRB2 (0.57) | RORCBDKRB2 | |
| SCHEMBL7811148 | 0.90 | BDKRB2 (0.58) | RORCBDKRB2 | |
| SCHEMBL7805379 | 0.87 | RORC (0.52) | RORCBDKRB2 | |
| SCHEMBL7815218 | 0.86 | RORC (0.57) | RORCBDKRB2 | |
| SCHEMBL7814998 | 0.86 | RORC (0.56) | RORCBDKRB2 | |
| SCHEMBL7814999 | 0.86 | RORC (0.56) | RORCBDKRB2 | |
| SCHEMBL7956401 | 0.85 | RORC (0.51) | RORCBDKRB2 | |
| SCHEMBL7815248 | 0.84 | RORC (0.50) | RORCBDKRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0874841-B1 | 1-BENZENESULFONYL PYRROLIDINE DERIVATIVES AS BRADYKININ RECEPTOR ANTAGONISTS | FOURNIER IND & SANTE (FR) | 2001-10-04 | — | — | EP | disclosed |
| US-6211181-B1 | ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIALLERGENS, AND ANTIASTHMATICS | FOURNIER INDUSTRIE ET SANTE (FR) | 2001-04-03 | — | — | US | disclosed |
| EP-0874841-A1 | 1-BENZENESULFONYL PYRROLIDINE DERIVATIVES AS BRADYKININ RECEPTOR B2 ANTAGONISTS | FOURNIER INDUSTRIE ET SANTE (FR) | 1998-11-04 | — | — | EP | disclosed |
| WO-1997024349-A1 | 1-BENZENESULFONYL PYRROLIDINE DERIVATIVES AS BRADYKININ RECEPTOR ANTAGONISTS | FOURNIER INDUSTRIE ET SANTE (FR) | 1997-07-10 | — | — | WO | disclosed |